数据链接：
官方服务：
资源简介：
Left ventricular assist device characteristics.
应用场景：
创建时间：
2018-06-01
相关数据集
Table3_Efficacy of Chinese traditional patent medicines for heart failure with preserved ejection fraction: a Bayesian network meta-analysis of 64 randomized controlled trials.docx
BackgroundHeart failure with preserved ejection fraction (HFpEF) is associated with substantial morbidity and mortality, and modern medicine offers less effective treatment for HFpEF. Much evidence sh
NIAID Data Ecosystem100
RRAD-reduction reveals efficacy of targeting L-type calcium channel regulation for treatment of heart failure
Heart failure with reduced ejection fraction (HFrEF) is a major health problem. Increasing L-type calcium channel (LTCC) activity deteriorates heart function; however, myocardial RRAD knockout (cRAD?/
NIAID Data Ecosystem20
Independent predictors for mortality.
BackgroundAchieving target doses of angiotensin receptor-neprilysin inhibitor (ARNI) in heart failure with reduced ejection fraction (HFrEF) is often challenging due to concerns related to hypotension
Figshare2025-07-28 更新10
MOESM4 of Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial
Additional file 4. Â Trial organization.
Figshare2016-12-15 更新60
Effects of β2-receptor stimulation by indacaterol in chronic heart failure treated with selective or non-selective β-blockers: a randomized trial
Raw data of the paper: Effects of β 2 -receptor stimulation by indacaterol in chronic heart failure treated with selective or non-selective β-blockers: a randomized trial
Zenodo2020-12-21 更新20
